Filana Therapeutics, Inc.
FLNA· Nasdaq
FLNAFilana Therapeutics, Inc.
Filed Aug 4, 2021 · 10-Q · 35 days after period end · 0001069530-21-000045
| Metric | Q2 2021 | Q2 2020 | Q2 2019 | Q2 2018 |
|---|---|---|---|---|
| Net Income | -$5.13M | -$1.14M | -$1.06M | -$2.45M |
| EPS Diluted | -$0.13 | -$0.05 | -$0.06 | -$0.36 |
The same fiscal quarter, prior years. Thaler holds no estimates to compare against.
Filana Therapeutics, Inc. · CIK 1069530 · Engraved from SEC EDGAR
ended Jun 30, 2021 · filed Aug 4, 2021 · 35 d after period end
